Alcoholism Clinical Trials 2023

Alcoholism Clinical Trials 2023

Alcoholism research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in alcoholism clinical trials today.

Trials for Alcohol Consumption Patients

Trials for Excessive Alcohol Consumption Patients

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to alcoholism

What are the top hospitals conducting alcoholism research?

When it comes to the battle against alcoholism, top hospitals are stepping up to the plate with innovative clinical trials aimed at finding effective treatments. In Charleston, South carolina, the Medical University of South Carolina leads the way with four active trials and a total of 25 trials conducted throughout their history. Since their first recorded alcoholism trial in 2009, this institution has been committed to exploring new avenues for helping those struggling with addiction. Meanwhile, in Philadelphia's University of Pennsylvania Center for Studies of Addiction, researchers are currently engaged in three ongoing alcoholism trials as they kickstart their journey into understanding this complex condition. Despite having only completed four studies since recording their initial trial in 2021, this center is making waves in the field.

At the University of Colorado Anschutz Medical Campus located in Aurora, three active alcoholism trials are taking place. Though relatively new to studying alcoholism compared to other institutions on this list (with their first recorded trial dating back only to 2020), they have already demonstrated a dedication towards advancing our knowledge and treatment options for individuals affected by alcohol addiction.

Notably contributing as well is Yale University situated in New Haven where two current clinical tests focus on combating alcoholism. With five previous investigations under its belt since initiating research efforts backin2016,Yale continues pushing forward toward breakthroughs that can transform lives.

Rounding out these leading medical centers is another establishment from Philadelphia—the University of Pennsylvania—where two active clinical trials concentrate on tackling alcoholism head-on.They have completed thirteen all-time studies thus far after embarking upon pioneering endeavors concerning such cases since1998

These hospitals' commitment and tireless efforts underline how crucial it is to find solutions for those grappling with addiction while fostering a sense of hope that through continued research we will uncover novel interventions and approaches leading us towards a society where recovery from Alcohol Use Disorder becomes more attainable than ever before

Which are the best cities for alcoholism clinical trials?

Providence, Rhode island, emerges as one of the top cities for alcoholism clinical trials with 9 ongoing studies focusing on Alcohol Use Disorder Only, Motivational + Family Check-up (MET+FCU), and Lamotrigine among others. Baltimore, Maryland follows closely behind with 7 active trials exploring interventions like Mifepristone, Pregabalin plus BBCET, and Intranasal Oxytocin. New Haven, Connecticut showcases its commitment to research with 6 ongoing trials investigating treatments such as patients receiving 300mg PREG, Active Treatment, and Guanfacine ER. Lastly, Philadelphia in Pennsylvania and New york City both contribute to advancing alcoholism treatment through their respective active trials including XR-NTX 380 mg intramuscular injection and Adaptive Tailored (TA) approaches. These cities offer individuals struggling with alcoholism opportunities to participate in innovative clinical trials that may improve outcomes for this challenging condition.

Which are the top treatments for alcoholism being explored in clinical trials?

Exciting advancements are taking place in the realm of alcoholism treatment, with clinical trials investigating several promising approaches. One notable contender is oxytocin, currently being explored in two active trials and a total of nine all-time alcoholism trials since its introduction in 2014. Another intriguing avenue under investigation is the use of alcohol itself as a potential treatment, with two ongoing trials and twelve all-time trials dedicated to exploring this unconventional approach since 2008. These innovative studies hold great promise for improving outcomes and providing new avenues for individuals struggling with alcoholism.

What are the most recent clinical trials for alcoholism?

Recent clinical trials have brought new hope for individuals struggling with alcoholism. One promising study investigated the effectiveness of Semaglutide, administered in 3 milligram and 7 milligram doses, as a potential treatment option. Another trial focused on Acetyl-l-carnitine and its impact on alcohol dependency. Additionally, Semaglutide was also studied independently to assess its effectiveness in combating alcoholism. Full-spectrum Cannabidiol has shown promise in Phase 2 and Phase 3 trials for treating alcohol use disorder. Lastly, Ibudilast is being evaluated in Phase 2 trials as a possible therapeutic intervention for those battling alcoholism. These exciting developments offer renewed optimism for improving outcomes and quality of life among individuals affected by this challenging condition.

What alcoholism clinical trials were recently completed?

Several recent clinical trials addressing alcoholism have achieved significant milestones, highlighting the ongoing efforts to combat this challenging condition. In December 2021, a trial sponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) concluded its investigation into ASP8062. Similarly, in September 2021, Dicerna Pharmaceuticals completed their trial evaluating the potential of DCR-AUD as a treatment option. Additionally, Denver Health and Hospital Authority accomplished an Enhanced linkage study in January 2021. These advancements in research signify crucial steps towards understanding and developing effective interventions for individuals struggling with alcohol addiction.